Treatment of Advanced-Stage Hodgkin Lymphoma: Let Us Face the Facts

被引：2
|
作者：
Borchmann, Peter [1 ]
Kreissl, Stefanie [1 ]
Diehl, Volker [1 ]
Engert, Andreas [1 ]
机构：
[1] German Hodgkin Study Grp, Cologne, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 24期
关键词：
TRIAL; ABVD;
D O I：
10.1200/JCO.2013.49.1811
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3045 / 3046
页数：2
相关论文
共 50 条
  • [31] The Complementary Prognostic Role of Baseline and Interim PET in Predicting Treatment Outcome in Advanced-Stage Hodgkin Lymphoma
    Cimino, Giuseppe
    Zaucha, Jan Maciej
    Cirillo, S.
    Saviolo, C.
    Hutchings, Martin
    El-Galaly, T. C.
    Borra, Anna
    Rago, Angela
    Gallamini, Andrea
    BLOOD, 2014, 124 (21)
  • [32] HLA-G expression and role in advanced-stage classical Hodgkin lymphoma
    Caocci, G.
    Greco, M.
    Fanni, D.
    Senes, G.
    Littera, R.
    Lai, S.
    Risso, P.
    Carcassi, C.
    Faa, G.
    La Nasa, G.
    EUROPEAN JOURNAL OF HISTOCHEMISTRY, 2016, 60 (02): : 143 - 148
  • [33] HIV-infection has no prognostic impact on advanced-stage Hodgkin lymphoma
    Sorigue, Marc
    Garcia, Olga
    Tapia, Gustavo
    Baptista, Maria-Joao
    Moreno, Miriam
    Mate, Jose-Luis
    Sancho, Juan M.
    Feliu, Evarist
    Ribera, Josep-Maria
    Navarro, Jose-Tomas
    AIDS, 2017, 31 (10) : 1445 - 1449
  • [34] Does interim PET increase the value of ABVD in advanced-stage Hodgkin lymphoma?
    Gallamini, A.
    Kostakoglu, L.
    ANNALS OF ONCOLOGY, 2015, 26 (06) : 1045 - 1047
  • [35] Brentuximab vedotin, nivolumab, doxorubicin, and dacarbazine for advanced-stage classical Hodgkin lymphoma
    Lee, Hun Ju
    Ramchandren, Rod
    Friedman, Judah
    Melear, Jason
    Flinn, Ian W.
    Burke, John M.
    Linhares, Yuliya
    Gonzales, Paul
    Peterson, Matthew
    Raval, Mihir
    Chintapatla, Rangaswamy
    Feldman, Tatyana A.
    Yimer, Habte
    Islas-Ohlmayer, Miguel
    Patel, Ameet
    Metheny, Leland
    Dean, Asad
    Rana, Vishal
    Gandhi, Mitul D.
    Renshaw, John
    Ho, Linda
    Fanale, Michelle A.
    Guo, Wenchuan
    Yasenchak, Christopher A.
    BLOOD, 2025, 145 (03) : 290 - 299
  • [36] Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis
    Xing, Katharine H.
    Connors, Joseph M.
    Lai, Anky
    Al-Mansour, Mubarak
    Sehn, Laurie H.
    Villa, Diego
    Klasa, Richard
    Shenkier, Tamara
    Gascoyne, Randy D.
    Skinnider, Brian
    Savage, Kerry J.
    BLOOD, 2014, 123 (23) : 3567 - 3573
  • [37] The validation of advanced-stage Hodgkin lymphoma international prognostic index (A-HIPI) in Turkish patients with classical Hodgkin lymphoma
    Koca, Oguzhan
    Ozyurt, Berk
    Umar, Aysenur
    Ozmen, Deniz
    Elverdi, Tugrul
    Salihoglu, Ayse
    Ar, Muhlis Cem
    Baslar, Zafer
    Eskazan, Ahmet Emre
    ANNALS OF HEMATOLOGY, 2025,
  • [38] Current treatment paradigms for advanced stage Hodgkin lymphoma
    Longley, Jemma
    Johnson, Peter W. M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 184 (01) : 60 - 71
  • [39] Treatment of newly diagnosed advanced stage Hodgkin lymphoma
    Uhm, Jieun
    Kuruvilla, John
    BLOOD REVIEWS, 2012, 26 (04) : 167 - 174
  • [40] Progress in Advanced-Stage Follicular Lymphoma
    Friedberg, Jonathan W.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (23) : 2363 - +
12345